Renal Cell Carcinoma — Trials

Renal Cell Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

1,622 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 376
Recruiting: 193
Ph III recruiting: 14
Growth YoY: +2.5%
Industry share: 33%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 39.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (276)

clinicaltrialsPublishedShowing 101–104 of 104 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06613269	68Ga-NY104 PET/CT Guided Radiation Therapy in CcRCC.(NYCRRT)	recruiting	Phase 2	40	Peking Union Medical College HospitalOTHER	1	Sep 27, 2024	clinicaltrials
NCT06265025	GM103 Intratumoral Injection in Patients With Locally Advanced, Unresectable, Refractory and/or Metastatic Solid Tumors	recruiting	Phase 1 / Phase 2	125	GeneMedicine Co., Ltd.INDUSTRY	1	Mar 21, 2024